ARCT

NASD Arcturus Therapeutics Holdings, Inc.
Oct 12, 2026 · 11:37 PM ET EOD Market Closed

$12.61 ↑ +0.00 (+0.00%) Trading Up from the previous close of $12.61, $1.14 below the day’s high of $13.75

YTD change
+105.71%
vs 20-day SMA
-11.56%
vs 200-day SMA
+45.49%

Price ranges

Previous day
$12.87 $14.32
open $13.18 close $13.74
+$0.56 (+4.25%)
Today
$12.57 $13.75
open $13.64 now $12.61
-$1.03 (-7.55%)
Past week
$12.03 $15.17
from $13.03 now $12.61
-$0.42 (-3.22%)
Past month
$12.03 $17.96
from $14.73 now $12.61
-$2.12 (-14.39%)
This year
$5.50 $17.96
from $6.13 now $12.61
+$6.48 (+105.71%)

Price & Performance

+4.15 (+49.05%) / 6M

$4.62$9.03$13.43$17.84Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.0% away from all-time highs of $1,321.04
  • ARCT is up 106% since the beginning of the year
  • ARCT is down 33% over the past 12 months
  • ARCT is down 14% over the past 1 month
  • 22% of all ARCT investors are betting against ARCT

ARCT reads not so good: price sits above one of the two key moving averages, the 12-month move is -35.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.34
Earnings momentum +55.4% Quarterly EPS growth
Quarterly change +55.4%

Valuation

P/E ratio N/A
Enterprise value $277.7M
Beta 2.62

Balance sheet & scale

IncomeN/A
Revenue$110.7M
Cash$251.5M
Debt$27.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $342.4M

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $762.81 +2.18%
IQV IQVIA Holdings Inc $262.21 +0.90%
CRL Charles River Laboratories International, Inc. $301.86 +0.02%
IT Gartner, Inc. $194.10 +1.54%
ICLR ICON Plc $164.40 +0.14%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.